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ABSTRACT 
Background and objective:  Hyponatremia is the most common 
electrolyte disorder in clinical settings and in hospitalized patients, and is 
found to be the most important predisposing factor of cardiovascular 
mortality among patients with heart failure. The fact is that the neuro 
humoral activation is similar to both acute myocardial infarction and 
heart failure. So our aim is to investigate the prognostic importance of 
hyponatremia in acute ST elevation MI and to establish its usefulness in 
predicting short term survival.  
Material: From June 2013 to June 2014, around 100 patients who 
presented with acute ST-elevation MI admitted in ICCU of Coimbatore 
Medical College Hospital, Coimbatore was studied.   
Method: 100 consecutive patients who were selected underwent detailed 
history and clinical examination. Their Plasma sodium concentrations 
were obtained on admission and at 24, 48 and 72 hours after that. The end 
point was to find the cause which caused mortality within 30days 
following myocardial infarction. 
Results:  The result of this study was found to be that, the proportion of 
patients who presented with acute ST elevation MI were hyponatremic at 
the time of admission or developed hyponatremia after admission. The 
30days mortality ratio was found to be high in hyponatremic group than 
normal group. There was also evidence that the severity of hyponatremia 
and mortality were having significant linear relationship. Multivariate 
analysis performed also showed that the significant independent predictor 
of 30days mortality was identified as hyponatremia on admission or early 
development of hyponatremia. 
Conclusion: By this study we conclude that hyponatremia at the time of 
admission or shortly after that in patient with acute ST elevation MI is an 
independent predictor of 30days mortality. A simple marker to find 
patients at risk is Plasma Sodium Levels. 
Key words: Hyponatremia, Acute myocardial infarction, Heart failure. 
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INTRODUCTION 
          Myocardial infarction is well known clinically and it is one of the 
major cause of death and disadilty worldwide, affecting all races and 
nationalities. It is found to affect any individual and can have profound 
deleterious, psychological and economic complication. 
           Acute coronary syndrome is a major public health problem in both 
developed and developing countries, and its gaining more importance in 
developing countries inspite of studies in the diagnosis and management 
for past 4 decades. Nowadays studies reveal that there is reduction in 
disease caused due to infection, and there is fast rise in ischemic heart 
disease and acute myocardial infarction in developing countries like India 
due to increased economic development and life style modification which 
promotes atherosclerosis. 
           Major efforts are necessary to strengthen primary prevention 
programmes at community level though there is wide disparity of 
available resources to treat AMI in developing countries like India.  
          Hyponatremia is one of the most common electrolyte disorder. In 
case of heart failure hyponatremia is the main predisposing factor for 
cardiovascular mortality. It is commonly found in inpatients, mostly in 
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surgical postoperative period and in patients with congestive cardiac 
failure, chronic glomerular nephritis and cirrhosis of liver. 
         Hyponatremia is commonly found after myocardial infarction, the 
fact is that the neurohumoral activation is similar to both acute 
myocardial infarction and heart failure.  
        The clinical improvement in hyponatremia is by rise in plasma 
sodium concentration. In the setting of acute myocardial infarction it is 
found that the data for the prognostic value of hyponatremia is lacking, 
even though in chronic heart failure the prognostic importance of 
hyponatremia is well established. 
      My concept of this dissertation is to study the prognostic importance 
of hyponatremia in acute ST elevation myocardial infarction and also to 
determine its usefulness in finding its short term survival. 
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AIMS AND OBJECTIVES 
         To determine the prognostic importance of hyponatremia in acute 
ST segment elevation myocardial infarction and to find out its usefulness 
in predicting its short time survival. 
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Heart and Vessels 
 
Fig-1, Fig-2 and Fig-3 shows: 
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 Right border - it is found slightly convex and is long formed by 
right atrium above and right ventricle below, it is in line with 
superior vena cava. 
 Left border - is formed majorly by left ventricle and a small 
portion by left auricle. 
 Inferior border - is formed by right and left ventricle. 
 Superior border - is formed by right and left atrium and great 
vessels. 
 Ligamentum arteriosum-  it extends from the origin of left 
pulmonary artery to the arch of aorta. 
 Arch of aorta- it gets arched into two planes, superiorly and to the 
left. The pulmonary artery bifurcates inferior to it. 
 Pulmonary artery- it get divided into right and left branch inferior 
to arch of aorta. Right branch passes under the arch. He branches 
lie just superior and parallel to the pulmonary vein. 
 Pulmonary veins- the right and the left pulmonary veins drain into 
left atrium. 
 Azygos vein- it begins from the abdomen and it arches over the 
right pulmonary vessels (and bronchus) and drain into SVC 
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Coronary Arteries 
Fig-4 
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Fig-5 
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CORONARY ARTERIES 
    Fig-4 and fig-5 shows: 
 Coronary artery- both right and left coronary artery oginate 
from left side of heart at the beginning of aorta.
[11]
 
 Right coronary artery- it is a smaller branch which arise from 
right aortic sinus and reaches the posterior surface of the heart by 
traveling in the coronary sulcus or groove, here it anastomose 
with the circumflex branch of left coronary artery. It gets lodged 
in anterior IV groove. It mainly supplies Right Atrium, small part 
of Left Ventricle near posterior IV groove, posterior part of IV 
septum, conducting system of heart except a part of LBB. In its 
course it gives off sinoartrial(SA) nodal branch which supplies 
right atrium and SA node; the marginal branch is a major 
branches which supplies anterior wall of right ventricle, in the 
posterior interventricular groove the posterior interventricular 
artery anastomose with anterior interventricular artery which is a 
branch of left coronary artery, near the posterior interventricular 
septum it gives off arteriventricular nodal artery. 
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 Left coronary artery- it’s a larger branch which arise from left 
posterior aortic sinus, it gets lodged in the posterior IV groove. It 
mainly supplies Left Atrium, great part of Left Ventricle, 
Anterior part of IV groove, RBB, part of LBB and 35% SA node. 
It gives a circumflex branch which get anastomose with right 
coronary artery on the posterior surface of heart by running 
posteriorly, in the interventricular groove it gives an anterior 
descending branch. 
 Anterior 2/3
rd
 of interventricular septum is supplied by ascending 
branch of left anterior descending artery, while posterior part of 
interventricular septumis supplied by right coronary artery. 
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ACUTE MYOCARDIAL INFARCTION 
Prevalence of AMI: 
                CVD is the most common cause of death worldwide nowdays 
and it causes around 15 million deaths in a year. CAD is found to 
increase in developing countries like India though there is decrease in 
incidence in the industrialized world for the past 3 decades. Compared to 
all other ethnic groups CAD is the major disease burden and death in 
Asian Indians. The disease occurs more commonly in younger age groups 
in India when compared to North America and Western Europe, and is 
found to be very severe, diffuse, complicated and with increased 
mortality.
[15,16] 
                  In Asian Indians CVD is found as a malignant form due to the 
underlying genetic susceptibility with abnormality in lipid and lifestyle 
factors. In Ethnic group the relevant risk factors are metabolic syndrome 
X, insulin resistance syndrome, lipoprotein(a), dyslipidaemic phenotype 
and few emerginf factors such as homocysteine, tissue plasminogen 
activator, fibrinogen, factor VII, PAI-1, infections and inflammations. 
                   More than half of world’s population resides in India. In this 
most of them lives in rural world, around 30% of mortality is found to be 
due to cardio vascular disease.  CVD is found to be more in urban than 
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rural society, when there 2 fold increase in cases in CVD cases in rural  
areas there is 9 fold increase in urban areas, as the risk factors such as 
obesity, hypertension, truncal obesity, low HDL, high cholesterol and 
diabetes mellitus are more in urban areas. In India most dominant form of 
CVD is Coronary Artery Disease. Nowadays in India death due to CVD 
is more when compared to other disease such as stroke. It is found to be 
four time higher than stroke, which is due to intake of  high calories diet 
from fat, more of diary products with low level of activity which is more 
in India than other parts of  the world. 
MYOCARDIAL INFARCTION (MI) - Revised Definition 
Acute, Evolving or Recent Criteria Of MI: 
1. Atleast one among the following given below, and biochemical 
markers of myocardial necrosis must show typical rise and gradual 
fall (troponin) or more rapid rise and fall (CK-MB)
[12]
 
• Typical anginal symptoms 
• ECG shows pathological Q wave 
• Ischemic ECG changes (ST segment elevation or 
depression) 
• Post coronary arterial intervention like CAG 
2. Acute MI- pathological findings. 
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Established Myocardial Infarction Criteria: 
1. Serial ECG reading shows appearance of new pathological Q 
waves. Depending upon the time since the development of infarct 
the biochemical markers may have normalized. Previous symptoms 
of patients may or may not be remembered.  
2. ECG finding suggestive of healing or healed MI 
Either one of the above criteria must get satisfied for established MI. 
ACUTE MYOCARDIAL INFARCTION- Causes 
           Coronary atherosclerosis with coronary thrombosis is the most 
common cause of MI. 
           Due to the development of rich collateral network, even high grade 
stenosis of epicardial coronary arteries which progress to occlusion does 
not cause STEMI. 
           Lipid laden atherosclerotic plaque can cause abrupt change, which 
leads to plaque disruption, which leads to platelet activation and 
aggregation due to exposure to certain substance which promotes it, 
which leads to thrombotic generation and finally leading to formation of 
thrombus. There is disruption of blood flow due to the thrombus formed 
which causes myocardial necrosis due to severe imbalance between 
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oxygen supply and demand. In few cases independent traditional risk 
factor may predispose to plaque rupture. 
Myocardial Infarction- Causes other than Coronary Atherosclerosis 
Arteritis  
• Chronic granulomatous disease( takayasu disease) 
• Leutic  
• Polyartheritis nodosa 
• Disseminated lupus erythematosus 
• Mucocutaneous lymph node (kawasaki) syndrome 
• Rheumatoid arthritis 
• Seronegative spondylo arthritis like ankylosing 
spondylitis(AS)              
   Coronary arteries trauma           
• Iatrogenic  
• Laceration 
• Thrombosis 
• Post radiation( treatment for malignancies ) 
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Mural thickening of coronary vessels with metabolic disease 
• Homocysteinuria 
• Amyloidosis 
• Mucopolysaccharidoses ( Hurler disease ) 
• Intimal sclerosis juvenile pattern 
• Fabry’s disease  
• Contraceptive steroids leading to intimal hyperplasis  
• Post partum period 
• Pseudoxanthoma elasticum 
• Radiation therapy leading to coronary fibrosis 
Other mechanisms leading to Luminal narrowing 
• Transient spasm of coronary vessels in case of prinzmetal 
angina 
• Coronary artery dissection  
• Post nitoglycerine withdrawal spasm 
• Aortic dissection 
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Coronary artery embolism 
• Infective endocarditis 
• Mitral valve prolapsed 
• Nonbacterial thrombotic endocarditis 
• Prosthetic valve replacement 
• Left atrium, left ventricle or pulmonary vein mural thrombus 
• Paradoxical emboli 
• Cardiac myxoma 
• Post CABG and CAG 
• Fixed embolus due to fibroelastoma of aortic valve 
• After intracardiac catheterization 
   Congenital anomalies to coronary artery 
•  Left coronary artery arising from sinus of vasalva especially 
anteriorly 
• Left coronary artery arising from pulmonary artery 
• Aneurysm of coronary artery 
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 Disproportion in the oxygen demand and supply in the myocardium 
• Aortic valve stenosis 
• Aortic regurgitation or incompetence 
• Incomplete differentiation of aortic valve 
• Thyrotoxicosis 
• Poisoning with carbon monoxide 
• Prolonged hypotension 
 Hematological causes of in situ thrombosis 
• Thrombocytosis 
• Polycytemia vera 
• Consumtive coagulopathy 
• Hypercoagulable state, thrombocytopenic purpura  
 Miscellaneous  
• Cocaine usage 
• Contusion of myocardium 
• Cardiac catheterization complication 
• Normal coronary arteries leading to infarction 
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Risk factor of CAD in Asian Indian 
       Fixed  
• Male – more than 25yrs  
• Female – more than 45yrs 
• Family history- premature CAD less than 5yrs 
        Modifiable factors- Non lipid 
• Systemic hypertension 
• Type II diabetes mellitus 
• Smoking 
• Morbid obesity or BMI more than 22 
• Serum homocysteine more than 10 micro mol/lit  
        Modifiable factors – Lipid 
• Serum total cholesterol- more than 150mg% 
• Serum triglycerides- more than 150mg% 
• LDL cholesterol- more than 100mg% 
• HDL cholesterol- Males->less than 40mg%,    
                                                Females->less than 50mg% 
• APO lipoprotein b- more than 100mg% 
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MYOCARDIAL INFARCTION- Pathophysiology: 
                Infarcts occur due to prolonged ischemia and hypoxia[1]. All 
acute infarcts is commonly caused by thrombosis which occlude coronary 
artery developed due to atherosclerotic plaque rupture, which leads to 
coronary vasospasm , when vessels get completely occluded, there is 
ischemia and hypoxia. The major initiating factor for unstable angina is 
thrombosis (i.e., blood clot) especially when there is recent and 
increasing rest pain. Thrombus formed in the coronary artery is the cause 
of sudden death in 50-60% of patients. Pre existing atheromatous lesion is 
the site usually where thrombus develops.
[13] 
                 A plaque is found to be dangerous when the lipid core occupy 
around 50% of plaque, when the macrophage density is more, when the 
smooth muscle density is very low, when the tissue factor is high and 
when the plaque cap is very thin. The rich lipid core and thin fibrous cap 
is found to have inflammatory reactions
[1]
. Proteolytic effect of the 
enzyme metalloproteinase’s on thin fibrous plaque cap is the reason for 
plaque rupture. There is accumulation of RBC’s, platelets, macrophages 
due to such rupture which leads to sudden occlusion and  RBC’s are rich 
in the thrombus formed. Thromboxane A2 is a powerful vasoconstrictor 
which is liberated from platelets, which leads to further 
vasoconstriction.
[13] 
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 Acute coronary syndrome may be of non ST- elevation MI or ST 
elevation MI. Non ST elevation MI or non Q wave MI or unstable angina 
occurs there is partial or complete lysis of clot due to natural fibrinolytic 
substance in the body leading to partial restoration of blood flow. ST 
elevation MI or Q wave MI occurs when there is no such fibrinolytic 
activity in the body. 
              The pathophysiology of acute myocardial infarction is complex 
and there are many other factors leading to infarct. 
 
The pathology of myocardial infarction by time after obstruction
 
                  
 
 
 
 
 
 
 
The above table shows the pathological changes in myocardial 
infarction according to the time of obstruction. 
           No changes in gross examination or by light microscopy in 
histopathology occurs in the first 30minutes of MI. Sometimes
mitochondrial swelling and glycogen loss can be seen in electron 
microscopy.    
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Myocardial fibers become wavy within 3 hours of infarct. Staining 
defect is seen between 2-3 hours of infarct. Within 12 hours of infarct 
there is loss of cross striation, coagulation necrosis, hemorrhage and 
edema. Within 24 hours of infarct there is ongoing coagulation necrosis, 
contraction band necrosis in the margins, pyknosis of nuclei, beginning of  
neutrofil infiltration and hypereosinophilia of myocytes. There is 
continued coagulation necrosis, loss of nuclei and striations and heavy 
neutofil infiltration occurs within 3days of infarct. Within 7 days of 
infarct there is necrosis of neutrofil, beginning of disintegration of dead 
muscle fibers and macrophage removal. Within 10days of infarct there is 
beginning of granulation tissue formation and increased phagocytosis of 
dead cell at border. Within 21 days there is mature granulation tissue with 
type 1 collagen. Within 8 weeks of infarct there is increased collagen 
deposition and decreased cellularity. More than 2 months there is dence 
scar formation. Once scar formed the actually age of infarct cannot be 
found. 
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MYOCARDIAL INFARCTION- Clinical features 
             Precipitating factors- vigorous physical exercise, emotional 
stress, medical or surgical illness is found in more than half of the patient 
with MI. Circadian variations is found between 6am- 12noon is reported 
in many cases, it can also occur in any time of the day or night.[19] 
               Clinical symptoms – The clinical hallmark is chest pain which 
is a deep visceral pain, similar in character and distribution to angina 
pain, very severe and prolonged lasting more than 20mins, it is present at 
rest and not responding to nitrates. The pain is heavy, squeezing, crushing 
type and sometime stabbing or burning[19].  Pain involves mainly the 
substernal region or in the epigastrium commonly radiate to the left 
shoulder or left arm. It may also get radiated to abdomen back and neck, 
abdomen, back and lower jaw. It does not radiate below the umbilicus. 
There may be weakness, sweating, nausea, vomiting, anxiety and feeling 
of impending death associated with pain.  
                 In patients with diabetes mellitus, prior heart failure, previous 
stroke and in older age group myocardial infarction may be painless
[19]
. 
Loss of consciousness, confusional state, profound weakness, arrhythmic 
appearance, peripheral embolisation or sudden drop in arterial pressure 
are the other features found in with or without pain in some patients. 
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 Sudden onset of breathlessness which progresses to pulmonary 
edema is found in increasing age group. 
 In cases of inferior wall myocardial infarction patient can presented 
with abdominal pain diarrhea and giddiness due to activation of 
parasympathetic nervous system. 
MYOCARDIAL INFARCTION- Physical findings             
  Patients usually try altering their position, stretching, moving 
around in the bed to relieve pain. They are anxious and restless. Common 
physical findings include pallor, peculiar facial expression, sweating, 
cyanosis, hypotension, arrhythmias (ventricular ectopic beats are more 
common), basilar rales, sinus tachycardia, pericardial friction rub, basal 
crepitations, raised JVP are seen. Sympathetic nervous system 
hyperactivity, tachycardia or hypertension are seen in patients with 
anterior infarct and parasympathetic hyperactivity, bradycardia or 
hypotension are seen in patients with inferior wall infarction. 
 Any one or more of the finding may be present such as rise in 
blood pressure and heart rate, presence of fourth heart sound, paradoxical 
splitting of second heart sound, decreased intensity of first heart sound, 
murmur of mitral regurgitation due to papillary muscle dysfunction, due 
to dysfunction of mitral valve apparatus a transient midsystolic, late 
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systolic apical murmur, dyskinetic segment around the apex, relief of pain 
by carotid sinus massage (Levine test) are seen. Apical impulse may be 
difficult to palpate in some cases. Decreased carotid pulse and raise in 
temperature to 38
0
c maybe observed. 
 MYOCARDIAL INFARCTION- Investigations 
                Investigations includes electrocardiogram, laboratory findings 
of cardiac injury enzymes and imaging. 
                 1. Electrocardiogram: 
 ECG is useful in confirming the diagnosis in both acute and chronic 
coronary syndrome. Depending on the factors given below the findings 
may get altered. 
 Duration-acute or evolving / chronic 
 Extent – transmural /nontransmural 
 Topography- anterior / inferior / posterior / right 
ventricular 
Classic pattern may get altered or masked in the presence of underlying 
abnormalities like bundle branch blocks and arrhythmias. 
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           ECG remains the most cost effective investigation in the diagnosis 
of acute as well as in chronic myocardial infarction. The ECG changes 
depends upon duration of ischemic process, extend of infarction. ECG 
leads are very helpful in localization of involved vessels. 
Normal ECG formation 
     
 
 
 
 
 
 
 
 P wave - upright wave in limb leads, biphasic in lead V1& V2. It 
occurs due to atrial depolarization. It always precedes the QRS 
complex. 
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 Q wave -occurs due to septal depolarization. First there is negative 
deflection, it always precedes the R wave. 
 R wave -it is first positive deflection of QRS complex and it occurs 
due to ventricular depolarization 
 S wave - follows R wave, it is negative deflection of QRS complex 
 T wave -it occurs due to ventricular depolarization it is usually 
upright  
 U wave - it occurs due to late ventricular repolarization of purkinje 
fibers.  
 
 
 
 
 
 PR interval- Impulse travel from SA node to both ventricles, the 
time taken is called PR interval, it indicated AV nodal period of 
conduction. It can be measured from starting point of P wave to 
starting point of QRS. Normal PR interval is 0.12-0.21 sec. 
 RR interval- useful in counting the heart rate. 
 QT interval- it occurs due to ventricular depolarization as well as 
repolarisation. Normal QT interval is 0.35
 QRS complex
depolarization. Normal QRS duration is 0.10
ECG changes in myocardial infarction according to the time of 
infarct: 
                   
 
 
                  
 
 
 
 
 
 
-0.45 sec. 
- the normal QRS occurs due to ventricular 
-0.12 sec 
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   The above picture shows the ECG changes in myocardial infarction 
according to time.  
                     There is subendocardial injury and myocardial ischemia 
from the onset and within 24 hours if infarction, in this there is ST 
segment elevation and T wave is peaked, R wave appears nearly normal.  
                     In the first day of infarction the ischemia and injury extend 
to the epicardial surface and at the site of severe injury there is area of 
subendocardial muscle dying, there is marked ST segment elevation and 
diminishing of R wave amplitude.    
Role of ECG in myocardial infarction: 
     There are 3 zones of injury occurring- ischemia, injury and necrosis. 
• Ischemia- is always reversible, the usual manifestation in ECG 
are ST segment depression and symmetrical T wave inversion. 
The horizontal and down going ST segments are relatively more 
specific for ischemia than up going ST segment. 
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• Injury- it is the next degree of ischemia which is severe. Its 
manifestation are hyper acute T waves and ST segment elevation 
(especially coving in type in upward convexity). It occurs in 
impending or ongoing infracted  patients. 
• Infarction – due to ST-T changes of injury the manifestation of 
infarction in ECG is usually pathological Q wave. (>0.04 
seconds, i.e., 1mm wide or >1/4 the size of the following R 
wave). 
[17]
 
    It is emphasised that diagnosis of myocardial infarction is usually 
based on the diagnostic triad such as history and clinical finding, ECG 
features and raised cardiac enzymes rather that one of the above 
parameter.   
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The Evolution Of An Infarct 
As time passes from hours to days to weeks to month there are 
series of changes in ECG pattern in myocardial infarction. This is called 
as evolution of ECG. Therefore it is important to take serial ECG’s t 
evaluate the stage or age of infarct. It is clinically and prognostically 
important to know the age to infarct as the risk of mortality and 
complications increases with passage of time.
[17] 
The Site Of Infarct 
It is important to know the site of infarct from ECG. Most infarction 
occurs in the left ventricle (20-25% occurs in the atria or right ventricle). 
Sites of infarction are divided into three- anterior, inferior and posterior.  
• Anterior infarcts: precordial leads L1 and aVL reflects anterior 
wall infarction. Extensive area is covered by anterior infarct so it is 
quite common, and is further divided into anteroseptal, 
anterolateral and extensive anterior infarcts. 
               When changes are confined to lead V1 and V4 anteroseptal 
infarction is diagnosed, if confined to lead V5 and V6 anterolateral 
infarction is diagnosed and extensive when all the chest leads shows the 
changes.  
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• Inferior infarcts: LII, LIII and aVF are the leads that reflect inferior 
wall or diaphragmatic infarction( as the inferior wall faces aVF) 
• Posterior infarcts: it is difficult to diagnose this infarct in ECG. It 
may be associated with inferior wall myocardial infarction 
manifesting only as reciprocal changes (ST-T changes opposite in 
direction to the changes seen in the area of infarction) in the 
anterior leads V1 to V4. 
  For a complete diagnosis of infarction from ECG, 3 parameters are 
required to be mentioned. 
         (a) site of infraction 
         (b) age or stage of infarction 
         (c) complications if present such as bradycardia, arrhythmia, heart 
block ,etc. 
    In about 20-25% of true infarct ECG is absolutely normal. The causes 
of ST segment elevation are as follows 
 Pericarditis 
 Left bundle branch block(LBBB) and WPW syndrome 
 Cor pulmonale 
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 Digitalis effect 
 HOCM 
 Quinidine therapy 
 Cardiac tumors 
  LV aneurysm 
 Juvenile T inversion, ERS 
 Prinzmetal’s angina 
 Non cardiac lesion with CVA 
 Trauma  
  DC cardio version. 
Localization of infarction by ECG: 
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• Anterior wall (anteroseptal): ST segment elevation in V1 and V4  
 
 
 
 
 
 
• High lateral wall infarction (apical): ST segment elevation in aVL, 
V5 and V6 . 
• Inferior wall infarction: ST segment elevation in II, III, aVF 
• Inferolateral wall infarction: ST segment elevation in II, III, aVF 
and in lead V5 and V6    
• Right ventricular infarction: always suspect right ventricular 
infarction when inferior wall MI occurs without any reciprocal 
changes. 
Diagnostic criteria are as follows: 
       (a) ST segment elevation in V3R or V4R or V5R. 
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       (b) Elevated ST segment in V1-V3 
       (c) ST segment elevation in V6R or V7R 
       (d) ST segment elevation in V1 and ST segment depression in 
  V2 
       (e) Regression of R wave from V1-V4 
         (f) ST segment elevation more in lead III than lead II 
       (g) ST segment depression in V2   
• Atrial infarction: 
- Always occurs with extensive ventricular infarction 
- Usually associated with atrial arrhythmias with large 
ventricular infarction 
- Incidence : 5-15% in right atrial infarction 
- Isolated atrial infarction is very rare, usually occurs in CCF 
patients 
- Rarely occurs in aluminum phosphide poisoning 
         
 
37 
 
ECG criteria to diagnose atrial infarction 
          (I)  Major criteria[14] 
 (i)  >0.5 mm elevation of negative deflection of Pwave in V5 and 
V6         with reciprocal changes in V1 and V2       
 (ii) Elevation of negative deflection of P wave >1.5mm in one 
   precordial leads (or) elevation of PTa >1.2mm in limb leads 
   with occurance of atrial arrhythmias 
 (iii)   Elevation of PTa in lead 1, with reciprocal changes in other 
   limb leads 
         (II)   Minor criteria 
(i) Presence of abnormal P wave, it may be irregular or notched 
(ii) Depression of PTa with reciprocal changes 
• Posterior wall MI- occurs due to ST depression with tall R 
and upright T wave in right precordial leads in a case of 
inferior wall MI 
Site Of Occlusion Of Coronary Arteries: 
• Occlusion of right coronary artery  
- Right ventricular MI 
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- Inferior wall MI 
- Posterior wall MI 
- Infero posterior wall MI 
• Left circumflex occlusion 
- Posterior wall MI 
- Lateral wall MI 
- High lateral MI 
• LAD occlusion 
- Anteroseptal MI 
- Extensive anterior wall MI and can present with 
BBB 
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To differentiate RCA and LCA occlusion in case of inferior wall MI 
• Elevation of ST segment in lead III > lead II- indicates RCA 
occlusion. 
• Elevation of ST segment in lead II > lead III- indicated LCA 
occlusion 
• Inferior wall MI with following changes always suggestive of 
LCA occlusion 
                        (a) ST depression V3: lead III ST elevation >1.2 
                        (b) ST depression in V1- V3 
                            (c) ST depression in aVL 
                         (d) ST elevation in aVL or V5 and V6 
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• Inferior wall MI with following changes suggestive of RCA 
occlusion 
         Proximal ST segment elevation in V1 
       Detection of LAD occlusion in a case of anterior wall MI 
   (a) Anterior wall MI with ST depression of >1mm in lead II, III, 
aVF- indicates proximal LAD occlusion 
    (b) Anterior wall MI with no ST depression in lead II, III, aVF- 
indicates distal LAD occlusion 
    (c) LAD occlusion proximal to septal branch 
• ST elevation in V1 >2.5mm 
• ST elevation in aVR 
• ST depression in V5 
• MI and right bundle branch block 
            (d) Proximal to diagonal branch  
• Abnormal Q wave in aVL 
• ST elevation lead I and aVL 
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Diagnosis of MI in the presence of LBBB 
 
 
    
 
 
 
 
 Sgarbosa criteria: 
• Elevation of ST segment >1mm + positive QRS complex- 5 
points 
• Elevation of ST segment >5mm + negative QRS complex- 2 
points 
• Depression of ST segment >1mm in V1-V3- 3 points 
           Total points ≥3 indicates MI 
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    Other criteria 
• Presence of  QS pattern inV1-V4 
• Regression of R wave from V1-V4 
• Q wave in two consecutive precordial leads or in two 
consecutive limb leads 
• Presence of positive T wave in lead V5 and V6 
• Left axis deviation 
• Presence of prominent S wave in V5 and V6 
Diagnosis of MI in the presence of RBBB   -Presence of RBBB will 
never mask the ECG changes of MI . 
A) Repolarisation (ST-T wave) abnormalities 
           The changes of ST segment is the earliest ECG finding found as a 
result of injury current of rest and injury current of activity. In acute 
myocardial infarction there is tall T wave with J point elevation and 
elevation of ST segment with upward convexity are the earliest 
manifestation. If the ischemia is dominantly transmural, deviation of ST 
segment towards the injured epicardial layer causing ST segment 
elevation, it indicates indicative change. In reciprocal changes there is ST 
43 
 
segment depression sometimes T wave inversion, which occurs when the 
leads get deviated towards uninjured surface eg., in AWMI there is 
reciprocal changes in inferior lead II, III, aVF. If it is a dominant 
subendocardial injury the reverse happens, the lead get shifted to 
uninjured layer which shows ST segment depression and lead aVR shows 
ST elevation.  
T wave become tall in very early MI, and peaked hyperacute MI. It 
last only for few hours and it is transient.ST segment change is 
accompanied by deep symmetrical inversion of T wave indicates 
myocardial injury. The T wave inversion may be associated with iso 
electric ST segment or sometimes with upward convexity or sometimes 
with ST segment depression. 
B) QRS changes  
 The lead over the infracted region shows QRS negativity and/or 
loss of QRS positivity. Repolarisation (ST-T) abnormality is 
accompanied by depolarization (QRS) changes. As a result of loss of 
electromotive force, sufficient myocardial tissues necrosis in the anterior, 
lateral or inferior leads show decrease R wave amplitude or Q wave. In 
subendocardial infarcts and transmural infarcts there is abnormal Q wave 
and in some cases there is no Q wave found. In these   region rarely there 
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is increase R wave in V1 and V2  without Q wave in any leads due to 
depolarization forces. 
C) Evolution of ECG changes 
         Within hours to days of infarction there is ischemic ST elevation 
and hyper acute T wave by formation of inversion of T wave and 
sometimes Q wave in the diagnostic leads. QT prolongation is found 
associated with these changes. The height of R wave is reduced. 
Superimposition of ST elevation on the pattern of an old infarction 
signifies a fresh infarction in the region ofprevious involvement. In days 
or weeks these changes in the ECG can resolve or may persist 
indefinitely. Complete normalization of ECG is not common but can take 
place. 
Mechanism involved in ECG changes                 
The ST elevation seen in ECG can be explained by two basic 
mechanisms. (i) Diastolic current of injury- there is primary TQ 
depression in this case due to the ST vector which will be directed away 
from the ischemic, negative, partly depolarised region during electrical 
diastole. For this baseline shift there is compensatory conventional 
alternating-current electrocardiogram, resulting in ST elevation. (ii) 
Systolic current of injury- in this case the cells are repolarised early and 
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the amplitude and velocity of the action potential is decreased so the 
ischemic zone is relatively positive. There is primary ST elevation as the 
injury current is oriented towards the electropositive zone. 
    Current of injury pattern with acute ischemia:  
                   (i) Subendocardial ischemia- in this the overlying leads   
record ST depression as the ST vector is directed towards the inner layer 
of affected ventricle and the ventricular cavity 
                  (ii)Transmural or epicardial injury- in this the leads record ST 
elevation as the ST vector is directed outward, in the contralateral leads 
reciprocal ST depression may occur. 
2) Laboratory findings: 
      i) Creatine kinase MB (CKMB) 
 Measurement of the myocardial isoenzymes of CK-MB is more 
specific in myocardial infarction. Creatine kinase starts to rise at 4-6 
hours of the infarct, peaks at 12hours and declines to normal within 2-3 
days. CK-MM, CK-MB, CK-BB are the three isoenzymes of creatine 
kinase. CK-BB is present in brain and kidney, CK-MM is present in 
skeletal muscles, CK-MB and CK-MM both are present in heart. The 
value for elevation of CK-MB is set few units above the upper limit as 
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CK-MB is present in healthy people also.  CK value is also elevated in 
skeletal muscle disease, cardioversion, hypothyroidism, skeletal muscle 
damage and stroke. CK-MB release in Skeletal muscle is detected for 
longer period than myocardial release, so a serial measurement showing 
rise and fall is very important which produces a plateau over several d 
ays, where skeletal muscle elevation lasts only for a short time  
.  
    
 
 
 
 
 
 
 
  ii) Cardiac specific Troponin (I and T)  
                 Cardiac and skeletal muscle contraction is under the control of 
specific protein troponin. Actin and myocin are the two other chief 
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protein involved in contraction-relaxation cycle of muscle. Through 
troponin complex, calcium initiates the contraction of muscle. 
                Troponin C (calcium binding), troponin T (tropomyocin 
binding protein) and troponin I (inhibitory) are the protein which 
comprises the troponin complex.                 
 
          
                 
 
 
 
 
  Cardiac TnI and TnT, though it is present in both cardiac and 
skeletal muscles, the gene and the aminoacid encoding differ so the 
antibodies formed also differ
[18]
. Troponin I is highly specific for cardiac 
muscle injury and it does not represent damaged skeletal muscles.      
The biomarker of choice for diagnosis of myocardial infarction is 
cardiac troponin. In myocardial injury, cardiac isoenzymes such as 
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cardiac troponin T and I has high sensitivity and high specificity. 
Monoclonal antibodies against epitopes is used in the detection, as they 
have negligible cross reaction with troponin of skeletal muscle origin. 
  By 3hours of chest pain, cardic troponin begin to rise above the 
reference limit, so only after 4 hours of coronary event cardiac troponin 
can be detected.after 12 hours test must be repeated to confirm the 
diagnosis. TnT peaks by 12 hours to 2 days and persist for 10-14days, 
TnI peaks by 24hours and persist 7-10days. 
Troponin T level is used for comparision with different laboratory 
as TnT can be measured by a single assay. 0.1ng/ml is the usual cut off 
point for cardiac muscle damage. 
  Troponin I differ in their cut off value, sensitivity and specificity as 
there is variety of assay. To obtain uniform concensus and to minimize 
the difference mentioned above, coefficient variance of less than 10% of 
99
th 
percentile of normal should be determined by each laboratory. 0.1-2 
ng/ml is the cut off point set for myocardial injury.                
Troponin is similar to CKMB in its sensitivity, as cardiac troponin 
remain elevated for 100-200 hours after acute MI and so this assay may 
be utilized for the evaluation of patients who present long after the 
episode of chest pain. 
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There is better prognosis and lower risk for adverse cardiac 
outcome if the cardiac troponin is not detectable after 12 hours of pain. 
Cardiac muscle injury can be detected but the cause cannot be detected by 
troponin level measurement alone, clinical assessment is required to 
determine the cause.  
Patients previously negative for other conventional cardiac 
biomarkers, cardiac troponin is found to be elevated, this is the most 
important advantage of cardiac troponin. Even when there is absence of 
ST segment elevation cardiac troponin is used in early and prompt 
diagnosis of acute myocardial infarction and can be treated early.   
It may also get elevated in sepsis, hypotension, atrial fibrillation, 
intracranial haemorrhage, myocarditis, pulmonary embolism and chronic 
cardiac failure[18] . Other causes are shown below   
  iii) Other cardiac injury enzymes     
 
               Aspartate aminotransferase(AST), Lactate dehydrogenase 
(LDH), myoglobin. CK and troponin are the first to rise, followed by 
AST and LDH. 
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   iv) Laboratory measurement 
• Leucocytosis develop within 2hours, reaches peak by 1day 
after MI  and return to normal by 1week. 
• Within 1-2 days of MI lipid profile must be estimated, as total 
and HDL cholesterol remains near baseline and fall after that. 
• ESR usually remains normal for 1 or 2 days and get raised 
after 4-5days and remain raised for days. 
• Due to hemoconcentration, hemotocrit  may rise after MI.   
3) Imaging 
 i) 2D Echocardiography 
                 Regional wall motion abnormality and ejection fraction can be 
assessed. For establishing prognosis, LV function is found after MI. 
Patients at risk of developing congestive cardiac failure, mechanical 
complications after MI and viable but stunned myocardium residual 
provocable ischemia can be detected in a early state. 
ii) Doppler Echocardiography 
                 Blood flow in the cardiac chamber and cardiac valves can be 
assessed. It is also useful in the assessment of the site of acute ventricular 
52 
 
septal rupture, acute cardiac tamponade, detecting the severity of MR or 
TR after MI and for finding the shut flow across the defect. 
 iii) Nuclear Imaging 
                    In MI radionuclide scanning, perfusion imaging, positron 
emission tomography, infarct avid scintigraphy are used in evaluation. 
Radionuclide scanning shows the site of necrosis and the extent of 
impairment of ventricular function. When clinical history, ECG findings 
and serum markers are not available cardiac radionuclide imaging is done 
for diagnosis. 
MYOCARDIAL INFARCTION- Diagnosis 
         Atleast two of the following is required to diagnose MI 
• Presence of ischemic chest pain. 
• Changes in the ECG pattern 
• Cardiac enzyme rise and fall 
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MYOCARDIAL INFARCTION- Complication 
       Myocardial damage leads to various adverse consequence and 
complications.  
 
 
 
 
 
 
 
 
 
 
 
• Recurrent chest pain- it occurs in 20-30% of patients after MI. 
Ischemia in the territory of original infarction, pericarditis, myocardial 
rupture, or pulmonary embolism may be the cause of pain.  
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• Acute pericarditis- it occurs in 10-15% of patients after 24-96hours 
of MI. Dressler syndrome is a autoimmune process with malaise, 
fever,pericardial pain.,which occurs in contrast to acute pericarditis 
after 1-8 weeks of MI. 
• Arrhythmias- cardiac rhythm abnormalities are common after MI  
 Intraventricular conduction delay, sinus bradycardia, AV 
block, accelerated junctional rhythm are the 
bradyarrhythmias and conduction disturbance seen. 
 Ventricular premature depolarization (VPDs), ventricular 
fibrillation(VF), ventricular tachycardia(VT) are due to 
electrical instability 
 Atrial fibrillation, paroxysmal ventricular tachycardia 
(PSVT) ,  sinus tachycardia occur due to pump failure or 
excessive sympathetic stimulation. 
• Cardiogenic shock- is an infrequent but serious complication of 
MI. Mortality is more than 50% in these cases. 
•  Mitral regurgitation 
• Hypotension 
• Left ventricular failure   
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Heart failure is the common complication which leads to mortality 
in patients with acute myocardial infarction. The mechanism involved is 
as shown in above. 
• Mechanical complications- aneurysm, ventricular 
pseudoaneurysm, free wall rupture, papillary muscle rupture, 
ventricular septal rupture. 
MYOCARDIAL INFARCTION- Management 
1) Anti ischemic treatment: 
        It reduces the oxygen demand and myocardial wall stress by 
reducing both preload and afterload. 
         Nitrates: In stable patients it is given sublingually 0.4mg every 
5min or buccal spray (0.3-0.6mg), if pain persist after 3 doses intravenous 
nitroglycerine 5-10 micro gram per min is advised. 
         Beta blockers: It reduces oxygen demand by lowering heart rate and 
blood pressure. It also has antiarrhythmic effect which is useful in 
controlling tachycardia, hypertension and continued angina.
[18] 
         Beta-blockers can be given orally or intravenously within first few 
hours of infarction which are useful in reducing mortality. Commonly 
used drugs are i) Metoprolol- 5mg IV over (1-2 min) repeated after 5min 
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for a total dose of 15mg, after 1-2hours followed by 25-50mg orally 6
th
 
hourly. ii) Esmolol: 50-300 mcg/kg/min 
        2) Control of pain: 
         Morphine: is given in a dose of 3-5mg IV, may be repeated every 
10-30min along with anti-emetic to control of chest pain. Beta-blockers, 
nitroglycerine, thrombolysis may also help in relieving pain. 
3) Antiplatelet therapy: 
        Aspirin: it is administered in a dose of 162-325mg non-coated 
formulations, early administration in patients with acute MI has great 
benefits, initial dose is followed by 75-160mg per day.   
         Clopidogrel:  in patients less than 75 years, loading dose of 300-
600mg followed by 75mg per day is given. In patients above 75years, 
75mg per day without loading dose is given. 
4) Thrombolytic or fibrinolytic therapy: 
                    It should be initited before 30min. Thrombolytic agent includes 
streptokinase(STK), urokinase(UK), tissue plasminogen activator(t-PA or 
alteplase), reteplace, tenecteplace, anisoylated plasminogen streptokinase 
activator complex(APSAC, antstreplase). It leads to generation of 
plasmin that lyses the clot. These drugs are not recommended in patients 
58 
 
with NSTEMI and unstable angina. In STEMI, when ST elevation is 
more that 2mm in two contagious precordial leads and 1mm in two limb, 
patients should be considered for reperfusion therapy. 
(i) Tissue plasminogen activator(tPA) -is give as 15mgIV 
bolus 0.75mg/kg(max 50mg) over 30min followed by 
0.5mg/kg over 60min (max 35mg) over next 30min. 
(ii) Streptokinase(SK)- 1.5 million units IV over 60min 
(iii) Tenecteplace(TNK)- 0.50 mg/kg IV bolus(total 
dose30-50mg) 
(iv) Reteplase(r-PA)- two 10 units IV boluses 
administered 30min apart. 
These drugs are absolutely contraindicated in active bleeding, 
haemorrhagic shock, intracranial aneurysm, aortic dissection, ischaemic 
stroke within 3months, etc.., 
5) Antithrombin therapy: 
         It is required before the completion of infusion of t-PA or 
tenecteplace, also in patients receiving STK. 
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(i) Heparin(UFH)- is given as initial bolus dose of 60 IU/kg (max of 
4000 units), followed by initial infusiom of 12 IU/kg/hour(max of 
1000units/hour) 
(ii) Deltaprin – given 12
th
 hourly, 120 IU/kg SC 
(iii) Fondaparinux- 2.5mg IV bolus, 2.5mg SC daily. It has decreased 
bleeding rates. Should not be used during PCI as it causes catheter 
thrombosis. 
(iv) Enoxaparin – given as 1mg/kg SC 12
th
 hourly. 
(v)Direct thrombin inhibitors- hirudin and bivalirudin is better in patients 
undergoing PCI than UFH. 
6) Percutaneous Coronary Intervention(angioplasty or stenting) 
         It is used in acute MI or in coimbination with thrombolytic therapy 
when thrombolysis fails or it can be given following thrombolysis. 
7) Calcium channel blockers: 
             In patients with STEMI for whom beta blockers are ineffective or 
contraindicated, Verapamil or diltiazem is used for relief of ongoing 
ischemia or for control of a rapid ventricular response in the absence of 
CHF, LV dysfunction or AV block. 
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8) Angiotensin converting enzyme inhibitor:  It acts by improving 
myocardial function by reducing myocardial remodelling, to be given in 
patients within 24hours with acute MI with or without congestive heart 
failure. 
9) Activity: 
        Patient without complication is advised for bed rest for first 12hours,  
within 24hours sitting is recommended, after 2-3days patient is advised to 
walk within the room, can increase walking progressively up to 600ft 
after 3days, at least for more than 3 times a day. 
10) Diet: 
        Nil per oral or clear liquids is given for first 4-12hours. 
Carbohydrate   should provide 50-55% and fat around 30% of total 
calories. High amount of potassium, magnesium and fiber must be 
provided with low sodium. 
11) Bowel: 
        Rich bulk of diet is given, rather than bed pan bed commode is given 
and stool softeners are used routinely. 
12) Sedation: 
       Drugs such as diazepam 5mg, lorazepam 1mg, alprazoam 0.5-
1mg is given for about 3-4 times a day.  
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Treatment protocol for acute coronary syndromes 
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  The above picture shows the treatment protocol for acute coronary 
syndrome. Most important of this is STEMI, which cause complete 
obstruction by thrombus, diagnosed by persistent ST elevation and left 
bundle branch block and confirmed by positive cardiac troponin. The 
main stay treatment for STEMI is fibrinolytic therapy, percutaneous 
coronary intervention or CABG. 
[18] 
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HYPONATREMIA 
DEFINITION: 
        Hyponatremia is defined as plasma sodium concentration less than 
135mEq/L. It indicates that the body fluids are diluted by excess of water 
relative to total solute. [20] 
When the sodium concentration is less than 120mEq/L it is severe 
hyponatremia, it is mild and asymptomatic in most of the cases
[3]
. 
Xubstantial neurological complication and mortality are the serious 
medical condition associated with severe form. Central pontine 
myelinolysis and extrapontine myelinolysis is found to be associated with 
correction of hyponatremia.
 
PATHOPHYSIOLOGY: 
• Low serum osmolality is usually seen when the plasma 
concentration of sodium is below 135mEq/L, it occurs due to 
retention of water or due to loss of sodium.
[20]
 
• In some cases of hyponatremia the plasma osmolality may be 
increased, it occurs in condition where there is accumulation of 
solutes in the ECF to become impermeable to glucose when there 
is insulin deficiency. Glucose is an effective osmole which draws 
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water from muscle cell, which causes hypertonic hyonatremia. It 
usually occurs in poorly controlled diabetes mellitus. For every 
100mg/dl rise in plasma glucose level there is 1.6 to 2.4mEq/L 
fall in Na
+
 concentration.  
•  Hypotonic hyponatremia is most commonly seen, it is mainly 
due to primary water gain or primary sodium loss
[20]
. Normally, 
suppression of ADH occurs when there is slight reduction in 
serum sodium, which occurs due to reduction in osmolality, 
resulting in excretion of dilute urine which normalizes sodium. 
•  Hyponatremia occurs due to factors such as (i) excessive intake 
of water, (ii) due to renal failure if there is reduced excretion of 
water by kidney
[3]
, (iii) due to inappropriate release of ADH 
[SIADH] or due to increased sensitivity to ADH, (iv) when urine 
flow in collecting tubule is very slow resulting in reduced 
excretion of urine, it occurs when there is increased salt and 
water reabsorption in the proximal tubule, resulting in low urine 
volume, slow flow and further concentration due to ADH. 
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CAUSES OF HYPONATREMIA: 
I. Hypotonic hyponatremia[29] 
a) Reduced effective blood volume 
 Increased ECF volume(primary NA+ gain exceeded by secondary 
water gain) 
• Congestive heart failure 
• Cirrhosis of liver 
• Nephrotic syndrome 
  Reduced ECF volume(primary NA+ loss followed by secondary 
water gain) 
• Renal loss of sodium: diuretics, osmotic dieresis, ketonuria, 
Addisons disease, salt-wasting nephropathy, post obstructive 
dieresis, nonoliguric acute tubular necrosis. 
• Extrarenal loss of sodium:  
     1) Gastrointestinal loss- vomiting, diarrhoea, tube drainage, 
    fistula, peritonitis, pancreatitis, obstruction. 
 2) Integumentary loss- sweating, burns. 
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  b) Normal or increased effective blood volume (primary water gain        
 followed by secondary NA
+
 loss) 
• Syndrome of inappropriate secretion of ADH(SIADH) 
• Chronic renal failure 
• Primary polydipsia 
• AVP release- because of pain, nausea, drugs 
• Glucocorticoid deficiency 
• Decreased intake of solute 
• Hypothyroidism  
   II. Isotonic or slightly hypotonic hyponatremia  
• Hyperlipidemia 
• Hyperprotinemia 
• Posttransurethral resection of prostate/bladder tumour. 
 III. Hypertonic hyponatremia 
• Hyperglycemia 
• Mannitol administration. 
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         Congestive cardiac failure, hepatic cirrhosis and nephritic syndrome 
are the most common cause of hyponatremia seen in ECF volume 
expansion which is usually associated with edematous state. Decreased 
effective circulatory arterial volume which leads increased AVP level and 
increased thirst are common disorders seen. Reduced GFR, increased 
proximal reabsorption of Na
+
 and water leading to delivery of decreased 
ultrafiltrate to the diluting site and treatment with diuretics are the 
additional factors which impair the excretion of solute free water. 
Prognostic factor of hyponatremia depends upon the severity of 
underlying condition 
           Increased AVP
[2]
 secretion results in impaired water excretion lead 
to decreased effective circulatory arterial volume or renal insufficiency, 
which causes absence of ECF volume contraction in hyponatremia.
[25] 
          Since increased AVP
[2]
 alone is insufficient to produce 
hyponatremia additional factors such as increased intake of water is also 
required. This results in rise of TBW, serum concentration of Na+ are 
decreased.  The most common form of this is syndrome of inappropriate 
ADH (SIADH). This is caused due to nonphysiological release of 
vasopressin from the posterior pituitary or from some ectopic source. 
Neuropsychiatric disorder (such as encephalitis, meningitis, CVA, head 
trauma, psychosis), malignant tumors (such as small cell carcinoma), 
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pulmonary diseases (such as tuberculosis, pneumonia, acute respiratory 
failure, positive pressure ventilation), major surgery (postoperative pain) 
and pharmacological agents (such as SSRIs, narcotics, antipsychotic 
agents, chlorpropamide, NSAIDs) are the most common cause of 
SIADH.[25] 
          Hormonal changes both excess and deficiency lead to 
hyponatremia. Changes such as adrenal insufficiency, hypothyroidism, 
decreased mineralocorticoids. Decreased cardiac output and GFR, 
increased AVP secretion in response to hemodynamic stimuli are the 
mechanism involved in hypothyroidism which leads to hyponatremia
[4]
. 
Renal failure if the kidney is  not able to excrete the dietary water load or 
absence of AVP are the causes which finally leads to hyponatremia. 
Adrenal insufficiency leads to hyponatremia due to decreased 
mineralocorticoids, but directly or indirectly it is the cortisol deficiency 
which leads to this condition.
[4] 
          Compulsive increased consumption of water which exceed the 
excretory capacity of 12liters/day is the cause of hyponatremia which 
occurs in polydipsia (psychogenic or primary), increased water 
consumption is because these patients are mostly having psychiatric 
illness and taking sensation which increases thirst by causing dry mouth. 
Diuretics are another important cause of hyponatremia. Thiazide diuretics 
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is almost always the cause of diuretics induced hyponatremia, it leads to 
Na
+
 and K
+
 depletion and retention of water due to AVP. There is 
limitation in the ability of AVP to cause retention in loop diuretics due to 
decrease in the tonicity of medullary interstitium and impair maximal 
urine concentrating capacity. 
            Beer potomania results in hyponatremia, it occurs in drinkers who 
consume beer in large volumes and poor intake of diatary protein and 
electrolyte.       
 CLINICAL FEATURES: 
          Hyponatremia per se does not produce any major symptoms. It 
produces osmotic water shift and decreased cellular osmolality which 
leads to various clinical presentation. This leads to increase ICF volume, 
which causes brain cell swelling or cerebral edema. Magnitude of the fall 
in plasma Na
+
 and rapidity of the disease determine the severity of the 
disease. The symptoms are fond to be neurological. 
[33] 
           In acute hyponatremia where the symptoms develop within 2 days, 
nausea and malaise is found when the Na
+ 
concentration is ~125mEq/L. 
When the concentration falls further below ~120mEq/L there is 
progression of symptoms to lethargy, headache, obtundation and 
confusion. When it further fall ~115mEq/L it leads to neurological 
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symptoms. There is hyponatremic encephalopathy and increased pressure 
in the skull when the water enters the brain cells. This leads to major 
symptoms such as nausea, headache, confusion, vomiting, seizures, 
respiratory arrest, brain stem compression and non cardiogenic fluid 
accumulation in the lung.    
            In chronic hyponatremia where the symptoms develop after 3 
days, there is adaptive mechanism that tend to minimize the rise in ICF 
volume and symptoms by defend cell volume.  
           Development of symptoms depends upon the drop on blood salt 
level. Because of neuronal adaptation the patients may tolerate if the drop 
is gradual even to a very low level.   
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DIAGNOSIS: 
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• To determine the cause of  hyponatremia, accurate history and proper 
physical examination is required. ECF volume status and effective 
circulatory arterial volume must also be assessed along with it. 
• Differential diagnosis: congestive heart failure, cirrhosis of liver and 
nephritic syndrome presents with expanded interstitial space and 
reduced circulatory volume. In hypothyroidism and adrenal 
insufficiency present with normal ECF volume and reduced 
circulatory volume. Euvolemic with SIADH. 
[21]
 
• Differential diagnosis can be narrowed by laboratory analyses such as 
(i) plasma osmolality, (ii) urine osmolality, (iii) urine Na
+ 
 
• Plasma osmolality: plasma osmolality of <275mOsm/l is found in 
most of the patients with hyponatremia. If the osmolality is around 
275-290mOsmo/l pseudohyponatremia and if it is >290mOsmo/l 
hyperosmolar hyponatremia can be ruled out. 
• Urine osmolality: excretion of large volume of dilute urine is the 
response to hyponatremia , it is around <100mOsmo/l and specific 
gravity around <1.003. This occurs in primary polydipsia, beer 
potomania, post -TURP. Impaired free water excretion is suggested if 
the urine sample is not dilute and it is due to appropriate or 
inappropriate secretion of ADH.
[21]
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• Urine sodium: it is used in differentiating between extrarenal and renal 
lose of sodium and to assess effective circulatory volume. There is 
increased sodium reabsorption in response to decreased circulatory 
volume, such that the Na+ in urine is <10mEq/l. if urine sodium is 
>20mEq/l it is due to salt wasting nephropathyincluding cerebral salt 
wasting, hypoaldosteronism, recent diuersis or ketonuria. If the urine 
sodium concentration is >20mEq/l and if the urine osmolality is 
greater than 100mOsm/l (inappropriate urine concentration), but the 
patient has normal Na+ balance and normal volume and associated 
with hypouricemia then it is due to SIADH. But due to increased 
proximal urate reabsorption  there is hyperuricemia in patients with 
hypovolemia contast to hypouricemia in SIADH.
[28]
 
 
 
 
 
 
74 
 
 
TREATMENT 
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Treatment in symptomatic patients  
• Childrens, post operative patients, brain injury, premenopausal 
females, pulmonary disease and hypoxia are the patients with high 
risk in symptomatic hyponatremia. 
• In this patients with impending herniation presents with seizures, 
obtundation, hyperemesis, neurogenic pulmonary edema, 
hypercapnic respiratory failure, dilated pupil and must be treated 
with 3% sodium chloride bolus over 10 min, until symptoms 
improve repeat bolus once or twice (2-4mmol/l), then continue 
treatment as for hyponatremic encephalopathy 
• Hyponatremic encephalopathy presents with headache, nausea, 
vomiting, altered mental status and seizure, this must be treated in 
a monitored setting with 3% sodium chloride, for every 2 hours 
serum sodium must be checked, when patient is symptom free or 
when rise in serum sodium is 10mmol/l in first 5hours - 3% sodium 
chloride can be stopped. 
• So in the first 48 hour the correction must not exceed 15-20mmol, 
correction to hypernatremic or normonatremic level must be 
avoided 
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Treatment in acute and chronic hyponatremic patients 
• The rate of correction, the intervention required, and the underlying 
disorders are the factors which determine the treatment of 
hyponatremia. The rate of correction depends on the acuity of 
development of disease and the neurological symptoms present.  
• The correction of hyponatremia requires addition of sodium or 
removal of water or both and also correction of the underlying 
disorder.  
• Asymptomatic hyponatremia: in mild asymptomatic patients 
generally no treatment is required. In general isotonic saline is used 
for Na+ repletion, when hyponatremia is associated with ECF 
volume contraction. There is normalization of sodium due to 
reduction in renal water retention if euvolemic state is restored. 
• Chronic asymptomatic hyponatremia: it is found to be 
asymptomatic for more than 3 months[6]. Usually no treatment is 
required due to risk of treatment induced toxicity is very high in 
this case, because cells get adapted to hypoosmolar state, so sudden 
normalization leads to increase in volume over load. The rate of 
correction in this type of patients is 6-8mEq/l over 24hours 
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duration. If the underlying cause in this case is life threatening the 
correction can be done as in acute symptomatic hyponatremia. 
•   Asymptomatic hypovolemic hyponatremia: isotonic saline is used 
to restore the intravascular volume. If the duration is not known 1L 
of 0.9% of normal saline can be given over 24 hours. Renal water 
retention is reduced and sodium level becomes normal if 
hypovolemic is brought to euvolemic state. 
• Asymptomatic hypervolemic hyponatremia: most common causes 
are congestive cardiac failure and cirrhosis of liver. As effective 
circulatory blood volume is decreased in this case, administration 
of fluid lead to worsening of volume overload state due to 
increased interstitial fluid. 
• The definitive treatment is to treat the underlying condition with 
supportive measures such as 
 Fluid restriction must be done which must be less than 
the daily urine output 
 Loop diuretics given to increase the water excretion by 
diuresis. 
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 Vasopressin antagonists such as coivaptan and tolvaptan 
also promotes dieresis 
 High dietary solute intake like high salt diet, high protein 
diet or oral urea increases water excretion and 
normalization of hyponatremia. 
• The amount of fluid restriction necessary depends upon extent of 
elimination of water. Formula used usually is    
          (Urine Na
+ 
+ urine K
+
)
 
/ Serum Na
+ 
  if value <0.5, 1L fluid 
can be given, if value is 0.5-1.0, 500ml/day can be given, if value >1 
the fluid given gets retained so in this patients high dietary solute and 
medications like diuretics and vasopressin antagonist must be 
considered. 
• Symptomatic hyponatremia: can be divided into acute and chronic 
symptomatic hyponatremia.
[22]
 
• Acute symptomatic hyponatremia: this usually presents with 
neurological dysfunction like cramps, weakness, fatigue, mental 
confusion, disorientation, coma and convulsion. In this rapid 
correction should be avoided, the rate of correction must not be 
more than 0.6mEq/L/hour. 
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• The most important complication of rapid correction are 
 Volume overload 
 Shrinkage of brain – it occurs when there is loss of 
organic acids leading to normalization of brain volume. 
 Central pontine myelinolysis- quadriplegia, dysarthria, 
dysphagia with altered level of consciousness are the 
major manifestation found in this. It occurs due to rapid 
osmotic shift leading to neuronal damage. MRI is the 
investigation of choice. Patient with hypokalemia, 
malnutrition and alcoholism are more prone to develop 
CPM. In these cases rapid correction must be done 1-
2mEq/l/hr for first 3-5 hours followed by 0.5mEq/l/hr for 
next 24hours.
[22]
 
• Chronic symptomatic hyponatremia: in this case rate of correction 
must be around 6-8mEq/l over 24hour period.  
• Modalities of treatment: addition of sodium or removal of excessive 
water must be done. Removal of excessive water load is required in 
most of the cases of hyponatremia because excessive water is the 
cause of hyponatremia. Hypertonic normal saline and loop diuretics 
are given in this case to remove excessive water and salt, in this 
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hypertonic saline leads to addition of salt. Loop diuretics 
administration does not alter the amount of sodium as there is 
excretion of isotonic urine occurs, so amount of sodium administered 
can determine the increase in amount of sodium in the serum. 
• Restriction of fluid is done if slow correction is requires in volume 
expanded subjects. Loop diuretics and increase sodium and potassium 
intake is advised if above is not possible. 
•  The formula for rate of correction is 
             Na
+ 
= [ Na
+
i+ K
+
i- Na
+
s]/ [TBW+1] 
Total body water can be calculated by lean body weight in kg×0.6 for 
men and 0.5 for women. It does not estimate the ongoing water or 
solute loss, it is only a rough guide.[23] 
•  Hypertonic saline: 
 It is the main stay treatment for all type of hyponatremia 
includes acute and chronic symptomatic hyponatremia 
 The usual indications are seizures, altered mental status, 
coma, muscle weakness and fatigue. 
 3% normal saline is commonly used, if not available 0.45% 
normal saline can be used. 
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 Rate of correction for acute cases is 1-2mEq/l/hr. If 
1.2ml/kg hypertonic saline will increases the serum sodium 
by around 1mEq/l. 2
nd
, 3
rd
 and 6
th
 hourly sodium level must 
be monitored. 
• Vasopressin receptor antagonist like conivaptan, tolvaptan can be 
used in the case of SIADH.  
• Lithium and Demeclocyclin can be given if unresponsive to other 
medications. It is not commonly used due to its side effect.  
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NEUROHUMORAL ACTIVATION FOLLOWING 
ACUTE MYOCARDIAL INFARCTION 
Acute myocardial infarction is followed by several systemic 
metabolic changes in human. Plasma insulin level fall initially which 
return back to normal values, the plasma concentration of 
catecholamines[30], cortisol, glucose, glycerol and cyclic adenosine 
phosphate increases following MI.
[35]
 According to the study done by 
Hilton P and Flear CT, there is confirmed evidence that hyponatremia, 
hypochloremia and uremia is present with patients with myocardial 
infarction and the degree of infarction is related well with these indices. If 
the sodium level is less than 130mEq/l in patients admitted in coronary 
care unit, the mortality is found to be higher.[8][35] 
Due to the sudden development of left ventricular dysfunction; or 
due to pain, nausea and stress; or due to analgesic and diuretics 
administration in acute myocardial damage there is nonosmotic release of 
vasopressin. This is the most common cause of hyponatremia in adults. In 
this case serum osmolality does not correlate with level of vasopressin, 
even though other neurohormones such as rennin or nor epinephrine rises 
along with vasopressin, this proves the importance of nonosmotic 
mechanism involvement.[27] Arterial underfilling due to carotid 
baroreceptors in addition with increased messenger RNA expression in 
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the hypothalamus are involved in the nonosmotic release of vasopressin. 
The vasopressin regulated water is up regulated in the collecting duct in 
heart failure due to the renal effect of vasopressin.
[26] 
 
 
 
 
                   
 
 
 
 
 
 
  Renin-angiotensin system is activated and catecholamine 
production is increased in myocardial infarction which may further 
aggravate hyponatremia. [30,31]There is reduction in renal water excretion 
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due to the above factors which decreases the glomerular filtration rate and 
there is delivery of tubular fluid to the diluting segment of nephron.
[5] 
From a study done by Szatalowicz VL, Schrier RW, Arnold PE, 
Chaimotivz C, Bichet D, Berl T found that the patients with congestive 
cardiac failure, there were detectable arginine vasopressin levels in 40-45 
patients and for the development of hyponatremia vasopressin is 
essential. In patients with congestive cardiac failure the severity of 
hyponatremia is directly proportional to the degree of neurohumoral 
activation. 
[24]
                    
Another study conducted in around 530 patients by Rouleau JL, the 
independent sign of poor prognosis in post infracted patient at the time of 
hospital discharge can be found by neurohumoral activation. 
[8] 
From a study conducted in around 56 patients with acute 
myocardial infarction by Sigurdsson A, Held P, Swedberg K found that 
mainly in clinical heart failure patients there is sustained neurohumoral 
activation after myocardial infarction and even in patients without clinical 
heart failure it is related to the magnitude of myocardial damage. 
From a study in around 970 patients by Goldberg A, Hammerman 
found that, during acute phase of myocardial infarction a very simple 
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marker of neurohumoral activation is hyponatremia and the long term 
development of heart failure and death can be predicted from this.
[36] 
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The above picture explains the mechanism of neurohumoral 
activation involved in myocardial infarction similar to hyponatremia. In 
this there is ventricular remodeling due to various risk factors leading to 
atherosclerosis causing myocardial infarction, which causes sudden death 
due to arrhythmias and ventricular dysfunction, if there is remodeling it 
leads to further ventricular enlargement leading to heart failure and 
sudden death due to pump failure. 
[7]
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MATERIALS AND METHOD 
SOURCE OF DATA: 
From June 2013 to June 2014, around 100 patients who presented 
with acute ST-elevation MI admitted in ICCU of Coimbatore Medical 
College Hospital, Coimbatore were studied. 
Studies conducted at Department of Cardiology Rambam Medical 
Center by Antony Goldberg, Haim Hammerman, Sirouch Petcherski, 
Alexander Zdorovyak, Sergey Yalonetsky, Michael Kapeliovich, Yoram 
Agmon, Walter Markiewicz, Doron Aronson and Rappaport Medical 
School by Haim Hammermam , Walter Markiewicz, Haifa, Israel proved 
that in ST- elevation myocardial infarction the incidence rate of 
hyponatremia was found as around 32% . i.e., 447 patients developed 
hyponatremia among 1047 cases.  
The sample size (n) can be calculated by the incidence rate 32% 
and the allowable error 30% by the formula----> n=4pq/L
2
,  
Where, p---> incidence rate 
             q---> 1-p 
             L---> allowable error 
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METHOD OF COLLECTION OF DATA 
             100 consecutive patients who presented with ST elevation MI 
were selected and they underwent detailed history and clinical 
examination. 
INCLUSION CRITERIA 
            All patients with myocardial infarction having following criteria 
were selected 
• More than 20minutes of chest pain 
• ECG alteration consisting of new pathological Q waves or ST 
segment and T wave changes which are diagnostic of MI in 
ECG 
• Elevation of cardiac enzymes such as creatinine kinase (CK-
MB) or cardiac troponin T and I levels. 
EXCLUSION CRITERIA 
              Acute coronary syndrome without ST elevation in ECG must be 
excluded. Patients who received thrombolytic therapy (tissue type 
plasminogen activators or streptokinase).Selected patients underwent 
detailed history and clinical examination. Their Plasma sodium 
concentrations were obtained on admission and at 24, 48 and 72 hours 
after that. 
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END OF THE STUDY 
           Following myocardial infarction the end point was to find all the 
cause of mortality within 30 days. Within 30 days of discharge of the 
patients the mortality data were collected from the patients or from their 
family though post card received, when there was no response telephone 
or direct visit was done to collect the data of the patients.  
             Ion selective electrode auto analyzer was used to determine 
plasma sodium concentration. 
STATISTICAL METHOD 
 Odd ratio 
 Mean standard deviation 
 Confidence interval 
 To find the association between 30dys mortality and 
hyponatremia, logistic regression tests such as univariate ad 
multivariate were done 
 Parametric and non parametric test which was suitable (for non 
continuous variable Chi square test, for continuous variable 
Analysis of variance, Z test, etc). 
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The youngest age group is - 30 years      
           The eldest age group is - 85 years 
           35% of cases were in the age group of 51-60 years which accounts 
for the maximum number of patients and 27% of cases were found in the 
age group of 61-70 years which accounts for the next highest number of 
patients. 
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Ratio of Male:Female were found as 4:1 in this study 
          80% were males, 20% were females among 100 patients studied 
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Table no-3 
Table showing baseline characteristic of cases  
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Hyponatremia on admission was present in patients with older age 
group than patients who presented with normal sodium level. 
          81% of male patients presented with hyponatremia hyponatremia at 
the time of admission and 77% of patients who developed hyponatremia 
after 72hours of admission. 
           Compared with patients with normal sodium level, patients who 
were smokers around 81%, who had anterior infarction around 83%, who 
were diabetic around 44.45%,who were hypertensive around 22.22%, 
who had lower ejection fraction around 50.11 ±13.26% of patients and 
who were killip class accounted around 1.06±0.24 were found to present 
with hyponatremia at the time of admission or 72hrs after admission.  
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Graph-1 
Mean age in various groups 
 
 
 
 
 
 
 
In Group 1 = Patients with normal serum sodium level (57.8years) 
In Group 2 = Hyponatremia at the time of admission (64.9 years) 
In Group 3 = Hyponatremia with in 72 hours of admission (56.61years) 
 
 
 
 
95 
 
Graph-2 
Sexwise distribution 
 
Group 1 = Patients with normal serum sodium level (60-70 cases) 
Group 2 = Hyponatremia at the time of admission (10-15 cases) 
Group 3 = Hyponatremia within 72 hours of admission ( around 20 cases) 
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Graph-3 
Risk factor in various groups 
 
 
 
 
 
 
 
Group 1 = Patients with normal serum sodium level (DM – 12.6, smoking 
-70,          HTN – 5.6) 
Group 2 = Hyponatremia at the time of admission (DM –27.5, smoking -
81,        HTN – 18.18) 
Group 3 = Hyponatremia within 72 hours of admission (DM – 44.45, 
smoking -61        HTN -22.22) 
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Graph -4 
Ejection fraction (%) in various groups 
 
           
 
 
 
 
 
 
Group 1 = Patients with normal serum sodium level (EF =44.6%) 
Group 2 = Hyponatremia at the time of admission (EF=40.36%) 
Group 3 = Hyponatremia within 72 hours of admission (EF=50.11%) 
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Hyponatremia on admission and at 72 hours and its outcome 
in terms of mortality 
 
 
 
 
 
Among 100 patients admitted with MI the mortality was found to be 8% 
      -71 Patients were found to have normal serum sodium level 2 patients 
died within 30 days of admission 
      -11 patients were found to have hyponatremia at the time of 
admission, 3 patients died within 30days of admission 
      -18 patients were found to develop hyponaremia within 72 hours of 
admission, 3 patients died within 30days of admission  
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Table showing severity of the hyponatremia and its outcome 
in terms of mortality 
 
 
    
 
 
 
With serum sodium level of <130mg/dl- the mortality was 100% 
    With serum sodium level between 131-134mg/dl- the mortlity was 
 11.11%  
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Odd’s ratio for 30 days mortality 
 
 
 
 
 
Group 1 = Patients with normal serum sodium level  
Group 2 = Hyponatremia at the time of admission  
Group 3 = Hyponatremia within 72 hours of admission  
          
        When group 1 was compared with other groups, the 30 days 
mortality Odd’s ratio was found to be more in groups with 
hyponatremia,(Odd’s ratio for Group 2=5.03 and Group 3=6.9) 
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Survivors and non survivors were also compared for various 
factors 
 
          
    
 
 
 
 
 
 
 
 
 
         Mortality of the patients were significant by statistics by serum 
sodium level. In patients who survived mean sodium level was found to 
be 136.96±1.92 and in patients who did not survive the mean sodium was 
134.09±3.53. 
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            Other significant factors which determined mortality were  age, 
sex, smoking, diabetes, hypertension,Killip class.  
             Including variables that had p value of <0.2 in univariate analysis 
, logistic regression analysis which is a multivariate analysis was 
performed to identify the factors which were independently associated 
with 30 days mortality, 
                                                 Table No 8 
                      Variables                  P value 
                         Age                   0.025 
                         Sex                   0.027 
                     Smoking                   0.198 
                  Hypertension                   0.027 
                     Daibetes                   0.027 
                    Killip class                  0.001 
                   Hyponatremia                   0.057 
                Ejection fraction                  0.050 
Hyponatremia was a important significant risk factor associated 
with 30 days mortality along with other factors in multivariate analysis, 
Which is clear from the above table. 
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DISCUSSION 
From our study we found that the high risk people are patients who 
presented with hyponatremia at the time of admission or developed 
hyponatremia shortly after the admission of patients with acute 
myocardial infarction. 
Acute ST elevation myocardial infracted patients who presented in 
our hospital were found to be hyponatremic at the time of admission or 
after admission in a substantial proportion of patients in our study. At the 
time of admission around 11% of patients (11 patients) were 
hyponatremic and first 72 hours of admission around 18% of patients (18 
patients) developed hyponatremia in our study. 
Antony Goldberg conducted a similar study and found similar 
findings, he observed that at the time of admission 12.5%of patients (131 
patients) were hyponatremic and 72 hours of admission around 19.9% of 
patients (208 patients) developed hyponatremia. 
Goldberg in his study also found that diabetes, anterior infarction, 
Killip class and patients with  lower ejection fraction where found in most 
of the patients who developed myocardial infarction and presented with 
hyponatremia. 
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We also observed that mortality was found to be increased in 
patients with hyponatremia in our study. Within 30 days of admission 
there were total of deaths were 8% (8 patients). In this 2.8% (2/71)of 
patients presented without hyponatremia, 27.5% (3/11) of patients who 
presented with hyponatremia at the time of admission and 16.67% (3/18) 
of patients who developed hyponaremia within 72 hours of admission. 
Similarly Goldberg in his study observed that mortality was found 
to be increased in patients with hyponatremia. Within 30 days of 
admission there were total of 105 deaths (10%). In this 6.2% (44/708) of 
patients presented without hyponatremia, 19.8% (26/131) of patients died 
presented with hyponatremia at the time of admission and 16.8% 
(35/208) of patients developed hyponaremia within 72 hours of 
admission. 
In our study there was higher mortality in patients who presented 
with hyponatremia when compared to the above study of Goldberg et al, 
and the mortality rate were almost equal in patients who developed 
hyponatremia shortly after admission. 
Concordance with the finding of Goldberg the 30days mortality 
Odd’s ratio was high around 5.03 and 6.9 in both patients who presented 
with hyponatremia at the time of admission and with patients who 
developed hyponatremia within 72hours of admission in our study. 
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Goldberg in his study showed that an independent risk factor for 30 
days mortality was hyponatremia, which is concordance with our study 
which showed that significant risk factor determining mortality is 
hyponatremia, when we compared the outcome among survivors and non 
survivors, it was found that apart from sex, age, hypertension, diabetes, 
ejection fraction, killip class of admission; hyponatremia was significant 
among them. In the multivariate logistic regression analysis, all the 
variables associated with mortality in survivors and non survivors were 
included. In this analysis the independent predictor which was significant 
for mortality was hyponatremia. 
Concordance to our study Goldberg et al aso showed that when the 
hyponatremia is severe mortality is high. In our study, when we divided 
patients into two groups depending on the level of sodium. 100% 
mortality was found in patients with sodium level <130mEq/l and 12% in 
patients with sodium level around 131-134mEq/l. so it is clear that there 
is mortality tend to increase with severity of hyponatremia. 
Flear CT conducted a similar study in patients with acute 
myocardial infarction in coronary care unit and absorbed that when 
plasma sodium was <130mEq/l the mortality was found to be highe 
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The different prognostic factors of myocardial infarction such as 
severity of left ventricular function, hemodynamic alteration and the 
extent of neurohumoral activation was to incorporate by the development 
of hyponatremia. Goldberg concluded that  development of hyponatremia 
is a marker which associate the above prognostic entities. 
The independent predictor of 30 days mortality were hyponatremia 
at the time of admission or development of hyponatremia within 72 hours 
of admission, was concluded from our study. 
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SUMMARY 
The important predictor of cardiovascular mortality in heart failure 
patients was hyponatremia in most of the patients. As the neurohormnal 
activation that accompanied were similar in both myocardial infarction 
and hyponatremia. So, in the setting of acute ST elevation MI and in 
predicting the usefulness in short term survival, the prognostic 
importance of hyponatremia was investigated. 
From our study it was clear that hyponatremia was present in 
substantial proportion of patients at the time of admission and developed 
hyponatremia within 72 hours of admission. When we compared with 
normal groups the Odd’s ratio for 30days mortality was found to be very 
high in patients who were hyponatremic. 
There were also findings which suggested there were linear 
relationship between hyponatremia and mortality. Among several 
variables in survivors and non survivors the significant risk factors of 
mortality was found to be hyponatremia in univariate analysis. Killip 
class on admission, age, sex, diabetes, hypertension, low ejection fraction 
were other factors which play significant role in mortality.
[34] 
Multivate analysis by logistic regression analysis was performed 
and identified hypontremia as independent predictor of mortality.  
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CONCLUSION 
From our study we concluded that in patients with ST elevation 
myocardial infarction patients who presented with hyponatremia at the 
time of admission and within 72 hours of admission had high mortality 
and so hyponatremia is a independent predictor of mortality. Patient at 
risk can be identified by a simple marker plasma sodium level.          
 
 
 
 
 
. 
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  PROGNOSTIC IMPORTANCE OF HYPONATREMIA IN 
ACUTE ST-ELEVATION MYOCARDIAL INFARCTION  
PROFORMA 
NAME:                                                        IP. NO: 
AGE:                                                           DOA: 
SEX:                                                           DOD: 
OCCUPATION: 
RELIGION: 
MARITAL STATUS: 
ADDRESS: 
TELEPHONE NO: 
STATUS AT DISCHARGE: 
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 PRESENTING COMPLAINTS:  
 I. HISTORY OF PRESENTING ILLNESS:  
   A. CHEST PAIN:  
• Site: Precordial/ Restrosternal Epigastric/ Shoulder/ Neck  
• Time of onset:  
• Nature: Squeezing/ Crushing/ Compressive/ Tightness 
• Radiation: Arm/ Back/ Epigastric/ Neck  
• Frequency: 
• Severity 
•  Aggravating Factor: 
•  Relieving Factor: 
•  Associated sweating:  
 B. BREATHLESSNESS:  
• Onset: Sudden/ Gradual  
• Grade: I/II/III/IV  
• H/O Orthopnea: Yes/ No 
117 
 
•  Wheeze: Present/ Absent  
• H/O PND: Yes/No  
       Associated symptoms  
 C. COUGH  
• Onset: acute insidious                             
• Productive/ Non Productive  
• Sputum: Quantity  
• Quality 
• Colour 
• Postural Variation 
• Haemoptysis: Yes/ NO  
 D. PALPATION 
• Onset: Acute/ Insidious 
•  Duration  
• Nature: intermittent/ continuous  
• Aggravating Factors: Exertion/ Excitement  
• Relieving Factors  
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 E. PRESYNCOPE/ SYNCOPE  
• Related to exertion             :          Yes 
• Postural relation                 :           Erect                          Supine 
• Frequency                          :           Isolated                      Frequent 
• Loss of consciousness       :           Yes                             No 
• Others                                :  
 F. SWELLING OF LEGS/ FACE  
• Onset: Acute/ Insidious  
• Duration: 
• Associated with pain: yes/ No  
• Diurnal Variation: Yes /No  
 G. NAUSEA /VOMITING  
 H. MISCELLANEOUS                          Present                          Absent  
• General weakness/ Fatigue  
• Altered sensorium 
•  Oliguria 
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•  Convulsion  
•  Others  
 II. PAST HISTORY  
• Past history :            Present/Absent  
• Duration  
• Treatment  
• IHD –Angina 
• Infarction 
• Hypertension 
• Diabetes  
• Rheumatic 
• Syphilis 
• Vascular heart disease 
• TIA/ Stroke 
• Any other  
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III. PERSONAL HISTORY  
  1. Diet                         Vegetarian                              Mixed  
  2. Sleep                       Sound                                     Disturbed  
  3. Appetite                  Good                                      Decreased  
  4. Bladder                   Normal                                   Polyuria/ 
Anuria/Dysuria  
  5. Bowel                     Normal                                  Constipated 
/Loose stools  
  6. Menstrual history   Normal /Irregular  
       Postmenopausal  
  7. Habits  
         a) Smoking              :  Duration  
         b) Alcohol               : Duration  
                                                    Type  
                                                    Quantity  
        c) Tobacco Chewing:  Duration  
                                            Quantity  
        d) History of exposure to STD:        Present/ Absent  
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 IV. GENERAL PHYSICAL EXAMINATION  
  1) Built                                      Well/Moderate                   Poor  
  2) Nourishment                         Obese/Average                   Poor  
  3) Emotional state                     Calm/Anxious                    Restless  
  4) Pallor                                    Present/ Absent  
  5) Cyanosis                               Present/ Absent  
  6) Icterus                                   Present/ Absent  
  7) Clubbing                               Present/ Absent  
  8) Pedal oedema                        Present/ Absent  
  9) Lymphadenopathy                Present/ Absent  
  10) Extremities                         Warm/ Cold  
 V. VITAL SIGNS  
  -Pulse  
  -Blood pressure  
  -Respiratory rate  
  -Temperature  
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 VI. SYSTEMIC EXAMINATION  
  CVS EXAMINATION  
           1) Pulse  
                     -Rate  
                             -Rhythm  
                             -Volume  
                             -Character  
                             -Condition of Vessel Wall  
                     -Radio Femoral Delay  
                  2) JVP –Normal /Raised  
         A. INSPECTION  
            Precordium                         Normal/Bulged  
           Apical impulse                    Visible / Non Visible  
           Other pulsation  
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       B. PALPATION  
         Apical impulse                     Location, Character  
                 Palpable                               Heart Sounds  
                 Thrills                                   Apex  
                                                               Parasternal area  
                 Any other  
      C. PERCUSSION  
        Cardiomegaly  
                Pericardial effusion  
      D. AUSCULTATION  
       Heart sounds  
       S3/S4                                     Present/ Absent  
              Murmur                                  
Timing/Location/Character/Radiation/Grade  
  Pericardial rub  
  Basal crepitations  
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 Others  
   
KILLIP CLASS:  
   
   
   
RESPIRATORY SYSTEM:  
   
   
PER ABDOMEN:  
   
   
CENTRAL NERVOUS SYSTEM  
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INVESTIGATIONS 
I. BLOOD  
HAEMOGLOBIN gm/dl 
TC  
DC 
Cells/mm
3
 
NEUTROPHILS % 
LYMPHOCYTES % 
EOSINOPHILS % 
BASOPHILS % 
MONOCYTES % 
ESR % 
CARDIAC ENZYMES:  CPK-MB IU/L 
Or TROPONIN T. IU/L 
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II.URINE  
ALBUMIN   
SUGAR  
MICROSCOPY  
 
III.BIOCHEMISTRY  
RBS                                                                                             mg/dl 
SODIUM LEVELS            ON ADMISSION                            mEq/L 
-AFTER 24 HRS                                                                         mEq/L 
 -AFTER 48 HRS                                                                         mEq/L 
-AFTER 72 HRS                                                                          mEq/L 
TOTAL CHOLESTEROL                                                             mg/dl 
HDL CHOLESTROL                                                                     mg/dl 
LDL CHOLESTROL                                                                      mg/dl 
VLDL CHOLESTROL                                                                    mg/dl 
TRIGLYCERIDE                                                                           mg/dl 
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IV.ELECTROCARDIOGRAPHY 
 V.ECHOCARDIOGRAPHY  
EJECTION FRACTION  
CONCLUSIONS  
OTHER RELEVANT INVESTIGATIONS  
  DIAGNOSIS  
      IN HOSPITAL COMPLICATIONS  
     CCF/LVF  
     Cardiogenic shock  
     Arrhythmias  
     Thromboembolism  
     Pericarditis  
     Rupture of Interventricular septum  
     Rupture of papillary muscle  
     Aneurysm  
     Any other  
   
      FOLLOW UP UPTO 30 DAYS  
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INFORMED CONSENT 
DEPARTMENT OF GENERAL MEDICINE 
Coimbatore Medical College, Coimbatore 
Principal investigator : Dr.  Jothibasu . V 
Research guide :           Dr. S. Chandrasekaran, M.D. 
Organisation :                Department of General Medicine 
Informed consent : I have been invited to participate in research 
Project Titled 
“PROGNOSTIC IMPORTANCE OF HYPONATREMIA IN 
ACUTE ST-ELEVATION MYOCARDIAL INFARCTION” 
I understand, it will be answering a set of questionnaire, undergo physical 
examination, investigations and appropriate treatment. 
I also give consent to utilise my personal details for study purpose and 
can be contacted if necessary. 
I am aware that I have the right to withdraw at any time which will not 
affect my medical care. 
Name of the participant : 
Signature : 
Date : 
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xg;g[jy;  gotk;; [ ; ;; [ ; ;; [ ; ; 
bgah; : 
ghypdk; :        taJ : 
Kfthp : 
 
 muR nfhit kUj;Jtf; fy;Y}hpapy; bghJ kUj;Jtj; 
Jiwapy; gl;l nkw;gog;g[ gapYk; khzth;; nkw;bfhs;Sk;  
"fLikahd khuilg;g[k; ,uj;jj;jpd; nrhoak; mst[ ; [ ; ; ; ; ; [; [ ; ; ; ; ; [; [ ; ; ; ; ; [
Fiwg;;;;ghodhy; Vw;gLk; gpd; tpist[fs;; ; ; ; [ ;; ; ; ; [ ;; ; ; ; [ ;" Fwpj;j Ma;tpy; 
bra;Kiw kw;Wk; midj;J tptu';fisa[k; nfl;Lf; bfhz;L 
vdJ re;njf';fis bjspt[g;gLj;jpf; bfhz;nld; vd;gij 
bjhptpj;Jf; bfhs;fpnwd;. 
 ehd; ,e;j Ma;tpy; KG rk;kjj;JlDk;/ Ra rpe;jida[lDk; 
fye;J bfhs;s rk;kjpf;fpnwd;. 
 ,e;j Ma;tpy; vd;Dila midj;J tpgu';fs; 
ghJfhf;fg;gLtJld; ,jd; Kot[fs; Ma;tpjHpy; 
btspaplg;gLtjpy; Ml;nrgid ,y;iy vd;gij bjhptpj;Jf; 
bfhs;fpnwd;. ve;j neuj;jpYk; ,e;j Ma;tpypUe;J ehd; tpyfpf; 
bfhs;s vdf;F chpik cz;L vd;gija[k; mwpntd;. 
 
,lk;  :       ifbahg;gk; / nuif 
ehs; : 
 
 
